Yang Y - Search Results

1

Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs.

Yang Y, Su Q, Wilson JM. Yang Y, et al. J Virol. 1996 Oct;70(10):7209-12. doi: 10.1128/JVI.70.10.7209-7212.1996. J Virol. 1996. PMID: 8794368 Free PMC article.

2

Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: biological efficacy study.

Engelhardt JF, Simon RH, Yang Y, Zepeda M, Weber-Pendleton S, Doranz B, Grossman M, Wilson JM. Engelhardt JF, et al. Among authors: yang y. Hum Gene Ther. 1993 Dec;4(6):759-69. doi: 10.1089/hum.1993.4.6-759. Hum Gene Ther. 1993. PMID: 7514445 Free article.

3

Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis.

Yang Y, Nunes FA, Berencsi K, Gönczöl E, Engelhardt JF, Wilson JM. Yang Y, et al. Nat Genet. 1994 Jul;7(3):362-9. doi: 10.1038/ng0794-362. Nat Genet. 1994. PMID: 7522742

4

MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses.

Yang Y, Ertl HC, Wilson JM. Yang Y, et al. Immunity. 1994 Aug;1(5):433-42. doi: 10.1016/1074-7613(94)90074-4. Immunity. 1994. PMID: 7533647

5

Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung.

Yang Y, Trinchieri G, Wilson JM. Yang Y, et al. Nat Med. 1995 Sep;1(9):890-3. doi: 10.1038/nm0995-890. Nat Med. 1995. PMID: 7585213

6

Upregulation of class I major histocompatibility complex antigens by interferon gamma is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo.

Yang Y, Xiang Z, Ertl HC, Wilson JM. Yang Y, et al. Proc Natl Acad Sci U S A. 1995 Aug 1;92(16):7257-61. doi: 10.1073/pnas.92.16.7257. Proc Natl Acad Sci U S A. 1995. PMID: 7638177 Free PMC article.

7

Clearance of adenovirus-infected hepatocytes by MHC class I-restricted CD4+ CTLs in vivo.

Yang Y, Wilson JM. Yang Y, et al. J Immunol. 1995 Sep 1;155(5):2564-70. J Immunol. 1995. PMID: 7650386

8

Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses.

Yang Y, Li Q, Ertl HC, Wilson JM. Yang Y, et al. J Virol. 1995 Apr;69(4):2004-15. doi: 10.1128/JVI.69.4.2004-2015.1995. J Virol. 1995. PMID: 7884845 Free PMC article.

9

Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy.

Yang Y, Nunes FA, Berencsi K, Furth EE, Gönczöl E, Wilson JM. Yang Y, et al. Proc Natl Acad Sci U S A. 1994 May 10;91(10):4407-11. doi: 10.1073/pnas.91.10.4407. Proc Natl Acad Sci U S A. 1994. PMID: 8183921 Free PMC article.

10

A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier.

Xiang ZQ, Yang Y, Wilson JM, Ertl HC. Xiang ZQ, et al. Among authors: yang y. Virology. 1996 May 1;219(1):220-7. doi: 10.1006/viro.1996.0239. Virology. 1996. PMID: 8623532 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

108,068 results

Search Page

Filters